Canary Stat™

Focused Liquid Biopsy Panel

The Canary Stat™ Focused Liquid Biopsy Panel test

140 genes + 76 PGx + 340 MSI Markers + 41 HRR genes + 17 Intronic Fusions, TERT Promoter.

Comprehensive comparison of Canary diagnostic solutions with other companies' offerings

Note: Green Color highlighted text indicated test results where Canary has a differentiated advantage.
Test Results	Canary Acuity™	Canary Pulse™	Top U.S. and Indian Competitors
Number of Genes Analyzed via NGS	1091 (+637 Variants)	468 (+37 Variants)	300-500
Therapeutic SNVs and InDels	✓	✓	✓
Amplifications and Deletions	✓	✓	✓
Fusions Genes	✓	✓	✓
Tumor Mutational Burden (TMB)	✓	✓	✓
Microsatellite Instability (MSI)	✓	✓	✓
Homologous Recombination Deficiency (HRD)	✓	✓	✓
Loss of Heterozygosity (LOH)	✓	✓	✓
Comprehensive Proprietary Database of FDA Approved/Clinical Trial Drugs for Corresponding Biomarkers	✓	✓	✓
Depiction of Cancer-Relevant Pathways	✓	✓	✗
Germline Variants Affecting Drug Metabolism	✓	✓	✗
Complete ACMG Oncology Germline Mutational Analysis	✓	✓	✗
In Development
TCR Clonality	✓	✗	✗
HLA Typing	✓	✓	✗

Comprehensive comparison of Canary diagnostic solutions


Test Results	Canary Acuity™	Canary Pulse™	Canary Focus™
Number of Genes Analyzed via NGS	1091 (+637 Variants)	468 (+37 Variants)	115+
Therapeutic SNVs and InDels	✓	✓	✓
Amplifications and Deletions	✓	✓	✓
Fusions Genes	✓	✓	✓
Tumor Mutational Burden (TMB)	✓	✓	✗
Microsatellite Instability (MSI)	✓	✓	✓
Homologous Recombination Deficiency (HRD)	✓	✓	✗
Loss of Heterozygosity (LOH)	✓	✓	✓
Comprehensive Proprietary Database of FDA Approved/Clinical Trial Drugs for Corresponding Biomarkers	✓	✓	✓
Depiction of Cancer-Relevant Pathways	✓	✓	✗
Germline Variants Affecting Drug Metabolism	✓	✓	✗
Complete ACMG Oncology Germline Mutational Analysis	✓	✓	✗